Status:
COMPLETED
Dialysis-Less Frequently In The Elderly
Lead Sponsor:
Dr. Christine White
Conditions:
Dialysis
End Stage Renal Disease
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
Thrice-weekly dialysis is the accepted standard of care for hemodialysis (HD) patients. Observational studies suggest that elderly HD patients do as well and have better quality of life with less dial...
Detailed Description
This single-center pilot study of 40 patients is designed to determine the feasibility and safety of a large randomized controlled trial examining the impact of hemodialysis frequency on well-being, a...
Eligibility Criteria
Inclusion
- Greater than equal 70 years old, planned ongoing in-center HD treatment
- Incident HD patient and still alive 7 weeks post HD initiation
- Patient or substitute decision maker provide informed consent
Exclusion
- Significant barriers to ascertainment of the patient-reported experience measures
- Patient currently admitted to hospital without Alternate Level of Care designation
- Patient non-adherent to dialysis prescription
Key Trial Info
Start Date :
June 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2023
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03787719
Start Date
June 27 2018
End Date
November 9 2023
Last Update
May 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston Health Sciences Centre (KHSC)
Kingston, Ontario, Canada, K7L 2V7